Capricor Therapeutics Inc ( CAPR ) shares are trading lower by 6.05% to $19.27 during Thursday’s session. The company earlier commenced its public offering of common stock.

What To Know: The company announced the pricing of its public offering of 4.41 million shares at $17.00 per share. The company granted underwriters a 30-day option to purchase an additional 661,800 shares.

The offering, expected to close on October 18, will raise approximately $75 million before expenses and commissions.

Piper Sandler & Co. and Oppenheimer & Co. Inc. are managing the offering. Capricor says the company plans to use the funds for product development, manufacturing, working capital, and general corporate purposes.

Stock Of The Day: Taiwan Semiconductor Breaks Out As Buyers Push Prices Higher

Should I Sell My CAPR Stock?

Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.

Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.

Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Capricor Therapeutics ( CAPR ) stock currently has an RSI of 61.26, indicating neutral conditions.

For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.